Pasar al contenido principal

APATITOS MULTIFUNCIONALES Y COCRISTALES FARMACEUTICOS ASOCIADOS A MATERIALES PARA REGENERACION OSEA GUIADA

PID2023-151538NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2023
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Otros (Other)

Multicomponent Oxicam–Metformin Salts:Towards a Strategy for Enhancing Solubility and Stability

  • Muñoz-Hernández, Estephany
  • Domínguez-Martín, Alicia
  • Choquesillo-Lazarte, Duane
Comunicación oral presentada en en GE3C 2026: XXXII Simposio del Grupo Especializado de Cristalografía y Crecimiento Cristalino, celebrado en Jaca del 13 al 16 de enero 2026, Close to 85% of the drugs produced in the United States and Europe are administered orally. However, one of the major challenges for their development is their low solubility and permeability[1]. The design of dual drug– drug pharmaceutical multicomponent materials (PMMs) has emerged as an effective strategy to overcome these limitations while enabling synergistic therapeutic benefits and combination therapy[2]. This approach is particularly relevant for type 2 diabetes, where metformin (MTF) is the first-line therapy and comorbid conditions frequently require concomitant non-steroidal anti-inflammatory drugs (NSAID) treatment [3,4]. Here, we report the synthesis and characterization of a new family of Oxicam–MTF salts involving Piroxicam (PRX), Meloxicam (MLX), and Tenoxicam (TNX). The salts were synthesized using mechanochemical and solution-based methods and characterized by X-ray diffraction, UV-Vis spectroscopy, and thermal analysis. Structural and computational studies revealed the role of supramolecular synthons in directing the salt formation and highlighted the relationship between molecular packing and physicochemical properties. These new materials enhanced MTF stability and displayed differences in fluorescence behaviour. Importantly, the incorporation of MTF increased the aqueous solubility of the Oxicams, while moderating the solubility of free MTF. This study provides a framework for designing PMMs with improved stability, solubility, and pharmaceutical performance., This research has been funded by the project GBRMat PID2023-151538NB-I00, supported by MCIU/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”. E.M-H. acknowledges financial support from Fundación Guatefuturo (Guatemala) through project PBC-2024-18.